Position in EXEL
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$305,729
+$56,882 QoQ
Shares Held
5,619
-3.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#514
of 751 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NWAM LLC holds $8,220,053 across 8 Biotechnology names. EXEL ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,129 | $5,031,378 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,680 | $1,047,547 | |
| 3 | INSM |
INSMED Inc
|
5,071 | $540,670 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
5,530 | $432,833 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
19,540 | $330,616 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
5,619 | $305,729 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
912 | $274,539 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
3,238 | $256,741 |
All Filings in EXEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $305,729 | 5,619 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $248,847 | 5,802 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $272,710 | 6,222 | Shares | Sole | 2026-02-04 | |
| 2025-03-31 | $201,583 | 5,460 | Shares | Sole | 2025-05-05 | |
| No filing history on record for this holder in this stock. | ||||||